查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1320076

银屑病治疗药物市场：按治疗类别、治疗类型、作用机制、给药途径、配销通路和用途- 2023-2030 年全球预测

Psoriasis Drugs Market by Therapeutic Class, Type of Treatment, Mechanism of Action, Route of Administration, Distribution Channel, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到2023年，全球干癣药物市场将成长至96.7453亿美元，年复合成长率为12.05%，预计到2030年将达到214.827亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球干癣药物市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对整体收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解自家公司在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球干癣治疗药物市场规模及预测为何？

2.在预测期内，COVID-19 对全球银屑病治疗药物市场的阻碍因素和影响为何？

3.在预测期内，全球银屑病治疗药物市场需要投资哪些产品/细分市场/用途/领域？

4.全球银屑病药物市场的竞争策略为何？

5. 全球银屑病药物市场的技术趋势和法律规范是什么？

6.全球银屑病治疗药物市场主要供应商的市场份额是多少？

7. 哪些型态和策略性倡议被认为适合进入全球银屑病药物市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 银屑病流行
      • 老年人口增加，斑块型干癣和干癣性关节炎盛行率增加
      • 牛皮癣药物的核准流程更容易
    • 抑制因素
      • 昂贵的治疗费用
    • 机会
      • 银屑病研究和研发药物不断增加
    • 任务
      • 药物副作用
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章银屑病治疗药物市场：依治疗类别

  • 介绍
  • 白血球介素抑制剂
  • 肿瘤坏死因子抑制剂

第7章牛皮癣治疗药物市场：依治疗类型

  • 介绍
  • 生物製品
  • 全身性治疗
  • 热带疗法

第8章银屑病治疗药物市场：按作用机制

  • 介绍
  • 白血球介素抑制剂
  • PDE4抑制剂
  • TNFα抑制剂

第9章银屑病治疗药物市场：依给药途径

  • 介绍
  • 口服
  • 胃肠外的
  • 局部的

第10章牛皮癣治疗药物市场：依配销通路

  • 介绍
  • 医院药房
  • 网路药房
  • 零售药房

第11章银屑病治疗药物市场：依用途

  • 介绍
  • 关节炎
  • 红皮病
  • 水滴
  • 间质性
  • 祖姓
  • 牌匾
  • 脓疱型

第12章美洲银屑病药物市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第13章亚太地区干癣药物市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第14章欧洲、中东和非洲银屑病药物市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第15章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第16章上市公司名单

第17章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-434CCDA051BC

The Global Psoriasis Drugs Market is forecasted to grow significantly, with a projected USD 9,674.53 million in 2023 at a CAGR of 12.05% and expected to reach a staggering USD 21,482.70 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Psoriasis Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Psoriasis Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Therapeutic Class, market is studied across Interleukin Inhibitors and Tumor Necrosis Factor Inhibitor. The Interleukin Inhibitors is projected to witness significant market share during forecast period.

Based on Type of Treatment, market is studied across Biologic Drugs, Small Molecule Systemic Drugs, and Tropical Therapies. The Tropical Therapies is projected to witness significant market share during forecast period.

Based on Mechanism of Action, market is studied across Interleukin Inhibitors, PDE4 Inhibitors, and TNF Alpha Inhibitors. The Interleukin Inhibitors is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Oral, Parenteral, and Topical. The Topical is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Application, market is studied across Arthritis, Erythrodermic, Guttate, Intertriginous, Nail, Plaque, and Pustular. The Intertriginous is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Psoriasis Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Psoriasis Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Psoriasis Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Psoriasis Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Psoriasis Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Psoriasis Drugs Market?

6. What is the market share of the leading vendors in the Global Psoriasis Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Psoriasis Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Psoriasis Drugs Market, by Therapeutic Class, 2022 vs 2030
  • 4.3. Psoriasis Drugs Market, by Type of Treatment, 2022 vs 2030
  • 4.4. Psoriasis Drugs Market, by Mechanism of Action, 2022 vs 2030
  • 4.5. Psoriasis Drugs Market, by Route of Administration, 2022 vs 2030
  • 4.6. Psoriasis Drugs Market, by Distribution Channel, 2022 vs 2030
  • 4.7. Psoriasis Drugs Market, by Application, 2022 vs 2030
  • 4.8. Psoriasis Drugs Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of psoriasis
      • 5.1.1.2. Rising geriatric population coupled with growing prevalence of plaque psoriasis and psoriatic arthritis
      • 5.1.1.3. Ease of process of approval of psoriasis drugs
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in psoriasis research and pipeline drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects of the medication
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Psoriasis Drugs Market, by Therapeutic Class

  • 6.1. Introduction
  • 6.2. Interleukin Inhibitors
  • 6.3. Tumor Necrosis Factor Inhibitor

7. Psoriasis Drugs Market, by Type of Treatment

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Small Molecule Systemic Drugs
  • 7.4. Tropical Therapies

8. Psoriasis Drugs Market, by Mechanism of Action

  • 8.1. Introduction
  • 8.2. Interleukin Inhibitors
  • 8.3. PDE4 Inhibitors
  • 8.4. TNF Alpha Inhibitors

9. Psoriasis Drugs Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Oral
  • 9.3. Parenteral
  • 9.4. Topical

10. Psoriasis Drugs Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Psoriasis Drugs Market, by Application

  • 11.1. Introduction
  • 11.2. Arthritis
  • 11.3. Erythrodermic
  • 11.4. Guttate
  • 11.5. Intertriginous
  • 11.6. Nail
  • 11.7. Plaque
  • 11.8. Pustular

12. Americas Psoriasis Drugs Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Psoriasis Drugs Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Psoriasis Drugs Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
  • 15.2. Market Share Analysis, By Key Player
  • 15.3. Competitive Scenario Analysis, By Key Player

16. List of Company Mentioned

17. Appendix

  • 17.1. Discussion Guide
  • 17.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PSORIASIS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. PSORIASIS DRUGS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PSORIASIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2022 VS 2030 (%)
  • FIGURE 5. PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2022 VS 2030 (%)
  • FIGURE 6. PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2022 VS 2030 (%)
  • FIGURE 7. PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 8. PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 9. PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 10. PSORIASIS DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 11. PSORIASIS DRUGS MARKET DYNAMICS
  • FIGURE 12. PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 22. PSORIASIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 23. PSORIASIS DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PSORIASIS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PSORIASIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 5. PSORIASIS DRUGS MARKET SIZE, BY INTERLEUKIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PSORIASIS DRUGS MARKET SIZE, BY TUMOR NECROSIS FACTOR INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. PSORIASIS DRUGS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PSORIASIS DRUGS MARKET SIZE, BY SMALL MOLECULE SYSTEMIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PSORIASIS DRUGS MARKET SIZE, BY TROPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 12. PSORIASIS DRUGS MARKET SIZE, BY INTERLEUKIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PSORIASIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PSORIASIS DRUGS MARKET SIZE, BY TNF ALPHA INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. PSORIASIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PSORIASIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PSORIASIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. PSORIASIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. PSORIASIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. PSORIASIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. PSORIASIS DRUGS MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. PSORIASIS DRUGS MARKET SIZE, BY ERYTHRODERMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. PSORIASIS DRUGS MARKET SIZE, BY GUTTATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. PSORIASIS DRUGS MARKET SIZE, BY INTERTRIGINOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. PSORIASIS DRUGS MARKET SIZE, BY NAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. PSORIASIS DRUGS MARKET SIZE, BY PLAQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. PSORIASIS DRUGS MARKET SIZE, BY PUSTULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. PSORIASIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 282. PSORIASIS DRUGS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 283. PSORIASIS DRUGS MARKET LICENSE & PRICING